Archived Grant Opportunity View - GO5344

Applications must address the objectives and desired outcomes described in section 1.3 of the grant guidelines.

Applications to this grant opportunity must propose research that addresses one of the six Streams of research.  An application may be submitted to one of the six Streams only.

The objective of this grant opportunity is addressed in the following six Streams:

Rare Cancers, Rare Diseases and Unmet Need

• Stream 1 – Conduct a clinical trial of new drug and/or non-drug treatments and therapies for rare cancers, rare diseases and/or unmet needs.
• Stream 2 – Conduct a clinical trial assessing the safety, effectiveness and acceptability, of neurostimulation for improving outcomes in patients with spinal cord injury.
• Stream 3 – Conduct a clinical trial assessing the safety, effectiveness and acceptability, of pharmacological and/or non- pharmacological interventions for improving outcomes in individuals with chronic pain.

Effective Health Interventions

• Stream 4 - Conduct a clinical trial of new drug and/or non-drug treatments and therapies in individuals who have been identified through molecular testing.
• Stream 5 – Conduct an implementation science trial to determine best ways to implement preventative health interventions, screening or diagnostic test, therapeutic agent, technology or model of care that is not in routine use in Australia.
• Stream 6 – Conduct a clinical trial assessing the comparative effectiveness and acceptability of health interventions in improving outcomes in individuals with complex chronic conditions, including comorbidities.

This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health. 

Further information on the Medical Research Future Fund is available from the Department of Health website.

Applications will only be accepted from NHMRC approved MRFF Eligible Organisations. A list of NHMRC approved MRFF Eligible Organisations is available from the GrantConnect GO Documents and from the MRFF Eligible Organisations Institutions list on the NHMRC website.

Applications must satisfy all the requirements set out in the Medical Research Future Fund (MRFF) CTA Initiative – 2021 Clinical Trials Activity Grant Opportunity guidelines

Individual grant applications must not exceed a budget of $3m.

Streams 1 to 6 – up to 5 years

$71,600,000.00

From $0.00 to $3,000,000.00

Applicants are advised to read the Grant Guidelines thoroughly and liaise with the Eligible Organisation that will submit the application to identify any specific requirements that the Institution might have.

Applications must be submitted electronically using NHMRC’s online granting system (Sapphire).

Minimum Data closes at 5:00 pm (ACT Local Time) on 22 June 2022

Questions should be submitted no later than 1:00 pm (ACT Local Time) on 22 June 2022.